Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Medtravest III ApS
APS
Active
CVR 44301407
Vestergade 48
Other financial service activities, except insurance and pension funding n.e.c. · NACE 6499
Est. 2023
— employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK -19K
EBITDA margin
100.0%
Equity ratio
99.5%
Financial strength
Net profit 2024
DKK -16K
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2024
Key figures
Annual report 2024
Revenue
DKK -19K
—
EBITDA
DKK -19K
—
Net profit
DKK -16K
—
Total assets
DKK 11,4M
—
Equity
DKK 11,4M
—
Employees
—
—
Company information
Legal name
Medtravest III ApS
CVR number
44301407
Legal form
Anpartsselskab
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
14. september 2023
Share capital
DKK 14.477.049
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren i forening med bestyrelsesformanden eller af to bestyrelsesmedlemmer i forening.
Company purpose
Selskabets formål er at finansiere og investere i MedTrace Pharma A/S (CVR-nr.: 36497661) og associerede virksomheder.
Contact
Address
Vestergade 48
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Other financial service activities, except insurance and pension funding n.e.c.
Companies in Silkeborg
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2024
Income statement
DKK thousands
Item
2024
Revenue
-19
Staff expenses
-0
EBITDA
-19
Depreciation & amort.
-0
EBIT
-19
Net financials
3
Profit before tax
-16
Tax
-0
Net profit
-16
Balance sheet
DKK thousands
Item
2024
Total assets
11.438
Equity
11.379
Long-term debt
0
Short-term debt
59
Total debt
59
Financial ratios
5-year trend
EBITDA margin
-1900200.0%
This company
15.8%
Market median
-12026682% vs market
2024
2024
Equity ratio
99.5%
This company
38.2%
Market median
+160% vs market
2024
2024
Return on equity
-0.1%
This company
18.4%
Market median
-101% vs market
2024
2024
Net profit margin
-1623700.0%
This company
8.1%
Market median
-20045779% vs market
2024
2024
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
2024
2024
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
2024
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2023-09-14 – 2024-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
JS
Jens Strathe
Management
Management
2025
—
—
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
ML
Mark Lund Andersen
Chairman
2023
—
—
PJ
Peter Juul Kristensen
Chairman
2023
—
—
TJ
Tore Jesper Andersen
Board of Directors
2023
—
—
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
STRATHE INVEST ApS
Company
33.3%
33.3%
2025
JUUL KRISTENSEN HOLDING ApS
Company
33.3%
33.3%
2025
MLU Holding af 10/1-2017 ApS
Company
10.0%
10.0%
2025
Bernt Skov Jensen
Individual
5.0%
5.0%
2025
WIIK INVEST ApS
Company
5.0%
5.0%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
JUUL KRISTENSEN HOLDING ApS
Medtravest III ApS
(this company)
Board network connections
Board members of Medtravest III ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Jens Strathe
Management
0 companies
Mark Lund Andersen
Chairman
0 companies
Peter Juul Kristensen
Chairman
0 companies
Tore Jesper Andersen
Board of Directors
0 companies